-
miR-18a, ALOXE3, and Ferroptosis in Glioblastoma
2026-08-22
The reference study identifies a miR-18a–ALOXE3 regulatory axis that promotes glioblastoma by weakening ferroptotic vulnerability and enhancing tumor-cell migration. Its combination of human tumor analysis, cellular perturbation, lipid mediator studies, and orthotopic modeling links lipid metabolism to both p53-SLC7A11-dependent ferroptosis and Gs-protein-coupled receptor–PI3K-Akt signaling.
-
Sisomicin Activity Against Clinical Isolates
2026-08-22
This study evaluated sisomicin against 565 clinical bacterial isolates and established a quantitative comparison with gentamicin, tobramycin, amikacin, butirosin, and kanamycin. Its main practical contribution was showing broad in vitro activity against most gram-negative bacilli, while also identifying resistance patterns that limited the value of sisomicin against gentamicin- and tobramycin-resistant organisms.
-
Y-27632 ROCK Inhibitor Workflow for Cancer Research
2026-08-21
Y-27632 provides a selective way to modulate ROCK-dependent actin organization while separating cytoskeletal effects from ribotoxic-stress signaling. This practical workflow adapts insights from a cancer study of the JNK–USP36–Snail1 axis for controlled morphology, localization, viability, and pathway experiments.
-
YAP–TEAD and Super-Enhancers in Ectoderm Commitment
2026-08-20
A 2026 Nucleic Acids Research study maps how super-enhancers and three-dimensional chromatin contacts regulate early surface ectoderm commitment from pluripotent stem cells. Its perturbation data identify YAP–TEAD, particularly TEAD activity, as a regulatory axis that promotes early super-enhancer establishment and activation of lineage-associated genes.
-
WST-8 Glucose Uptake Assay Kit for Metabolism
2026-08-20
Measure cellular glucose uptake without radioactivity using a 2-DG, NADPH, and WST-8 colorimetric workflow. This assay is particularly useful for connecting autophagy defects, insulin resistance, hepatic steatosis, and treatment responses to a quantitative metabolic phenotype.
-
Annexin V-APC/7-AAD Apoptosis Kit Workflow
2026-08-19
Convert phosphatidylserine exposure and membrane damage into a practical, two-parameter cell-death readout for drug-response, leukemia, and immune-cell experiments. This workflow emphasizes clean controls, rapid acquisition, and mechanistic interpretation rather than treating every Annexin-positive event as equivalent.
-
DFO for Porous-Surface Fingerprint Detection
2026-08-19
DFO, or 9H-1,8-Diazafluoren-9-one, is a fluorogenic reagent for amino acid-based latent fingerprint visualization on porous materials. This guide combines substrate-aware forensic workflow design with a mechanism-first lesson from contemporary ferroptosis research.
-
PX-478 2HCl Workflows for HIF-1α Studies
2026-08-18
PX-478 2HCl provides a practical chemical perturbation tool for testing HIF-1α-dependent responses in hypoxia models, cancer cell lines, and radiosensitization experiments. This guide connects validated product parameters with assay controls, metabolic readouts, and cautious extensions inspired by recent macrophage and sepsis research.
-
Ellagic acid for CK2 and Senescence Assays
2026-08-18
Ellagic acid provides a chemically defined route to interrogate CK2 activity, apoptosis, and oxidative-stress phenotypes alongside senescence-focused screens. This guide converts the reference study’s machine-learning strategy into practical controls, concentration ranges, and troubleshooting steps without assuming that every CK2 response is a senolytic effect.
-
Annexin V-PE Apoptosis Detection Kit Guide
2026-08-17
Use the Annexin V-PE Apoptosis Detection Kit to connect treatment exposure with phosphatidylserine externalization in live cells. Its rapid, fixation-free format supports both flow-based population analysis and microscopy-based localization, making it useful for separating inflammatory modulation from treatment-related cell loss.
-
Saracatinib (AZD0530) Assay Workflow
2026-08-17
Saracatinib (AZD0530) combines potent Src-family kinase inhibition with Abl activity for mechanistic cancer biology, proliferation, and migration studies. This workflow connects pathway-level validation with practical cell-based and xenograft-oriented assay design while clarifying how SFK signaling may also inform synaptic research.
-
Metal-Free Carbon Nanozymes for ALP Detection
2026-08-16
Hsieh and colleagues developed a metal-free carbon-dot nanozyme assay in which alkaline phosphatase hydrolysis of pyrophosphate releases catalytic activity and generates a colorimetric turn-on signal. Kinetic analysis identified pyrophosphate as a noncompetitive inhibitor at a binding site distinct from the nanozyme active site, supporting sensitive ALP measurement over 0.010–0.200 U/L with a 0.009 U/L detection limit.
-
Hoechst 33342 for Translational HPH Cell Crosstalk
2026-08-15
Hoechst 33342 is more than a routine nuclear stain: deployed with mechanistic controls, it can connect hypoxia-induced endothelial–smooth muscle cell phenotypes to translational imaging endpoints in pulmonary hypertension research.
-
Platycodin D–RFC4 Signaling in NSCLC
2026-08-14
A 2026 Molecular & Cellular Proteomics study combines thermal proteome profiling, stability assays, docking, and multidimensional omics to identify RFC4 as a candidate target of platycodin D in non-small cell lung cancer. The work connects RFC4 engagement with impaired Notch1 and Notch3 signaling, altered ubiquitination, and apoptosis, while also illustrating how natural-product target discovery can be experimentally triangulated.
-
Vacuolin-1 in Lysosomal Exocytosis Assays
2026-08-14
A scenario-based guide to using Vacuolin-1 (SKU C4084) to improve experimental interpretation in lysosomal exocytosis, β-hexosaminidase release, and membrane-repair studies. It covers compatibility, dosing, controls, data interpretation, and practical criteria for selecting a reliable inhibitor.